Fifty-six endothelial-derived urinary bladder tumor samples collected from 26 animals with bovine enzootic hematuria were selected for immunohistochemical studies. Expression of factor VIII-related antigen (FVIIIra), CD31, muscle-specific actin, uroplakin III (UPIII), and the cell cyclerelated proteins cyclin D1 and p53 was evaluated in hemangiomas, ''hemangioendotheliomas'' (a vascular tumor that histologically is intermediate in appearance between a hemangioma and a conventional hemangiosarcoma), and hemangiosarcomas. Although CD31 expression was seen in all endothelial tumors tested, FVIIIra was not expressed in poorly differentiated endothelial tumor cells from solid areas or in 7 muscle-invasive hemangiosarcomas. Cyclin D1 overexpression was seen in 53% of hemangiomas, 82% of hemangioendotheliomas, and 95% of hemangiosarcomas. P53 immunoreactivity was only seen in muscle-invasive hemangiosarcomas. The UPIII staining pattern, normally very intense on the apical aspect and cytoplasm of superficial urothelial cells, was altered in the urothelium in an estimated 25% of hemangiomas, most hemangioendotheliomas, and most hemangiosarcomas. In conclusion, CD31 is a better marker than FVIIIra in the characterization of bovine endothelial tumors. The cell cycle regulatory pathways involving cyclin D1 and p53 seem to be impaired in endothelial urinary bladder tumors, p53 immunoreactivity positively correlating with enhanced invasion.
Introduction
Chronic ingestion of bracken fern (Pteridium spp.), the only plant known to cause cancer naturally, 14, 45, 46 produces a neoplastic syndrome in cows known as bovine enzootic hematuria (BEH), which is characterized by the occurrence of hematuria and urinary bladder tumors. 10 Moreover, in approximately 62% of the cases, multiple tumors occur in the same bladder. 10 This syndrome occurs worldwide and is very common in cows on Sã o Miguel Island, Azores, Portugal, where bracken grows endemically. As a complexing factor, bovine papillomavirus type 2 (BPV-2) is frequently associated with bracken-induced tumors of the urinary bladder, 4, 7 and 84 of 200 bladder tumors collected at the slaughterhouse on Sã o Miguel Island displayed BPV-2 DNA. 35 Exposure to the BEH carcinogen(s) causes the development of bladder cancer with diverse morphologies. 10, 34 Metastases are known to occur, namely to the lumboaortic lymph node, 38 but no extensive study on the frequency of metastatic disease has been performed so far. Histologically, among the epithelial-derived tumors, transitional cell carcinoma is the most common neoplasm. 10, 34 Endothelial-derived urinary bladder tumors are also quite common in BEH, 8, 10 ranging from welldifferentiated cavernous hemangiomas to solid hemangiosarcomas. This is a very heterogeneous group of tumors, and although some tumors present as clear-cut hemangiomas and hemangiosarcomas, others possess nearly all of the features of a hemangioma but also display increased cellularity and mitotic activity or contain well-formed vascular channels not well-demarcated and confined to the lamina propria, as is the case in most hemangiomas. Hence, in BEH, some authors use the designation ''hemangioendothelioma'' for those vascular tumors that histologically are intermediate in appearance between a hemangioma and a conventional hemangiosarcoma. 10, 32, 33 Two of the antibodies most commonly used in the diagnosis of endothelial tumors are directed to FVIIIra and CD31. FVIIIra, also referred to as von Willebrand factor, is a soluble plasma protein, carrier of factor VIII, and present in the Weibel-Pallade bodies of endothelial cells. 2 It is commonly used as a marker for endothelial cells in Vet Pathol 46:211-221 (2009) humans but was seldom expressed in some poorly differentiated vascular tumors. 23, 36 The platelet/ endothelial cell adhesion molecule CD31 (PE-CAM-1) is a transmembrane glycoprotein, expressed in platelets, monocytes, and endothelial intercellular junctions.
Angiosarcomas are among the rarest malignancies in human pathology, and only 12 cases have been described in the bladder. 40 Hemangioendothelioma is a rare vascular tumor of low-grade or borderline malignancy that arises in several organ systems, skin, and soft tissue, 6, 12 but to our knowledge, in humans no cases have been described in the urinary system. Hemangioma is the most common vascular lesion described in the World Health Organization classification of urinary bladder tumors in humans and is supposedly of congenital origin. 11 Spontaneous bladder tumors of urothelial type are common in dogs but rare in all other species. 28 In dogs, hemangiomas, ''hemangioendotheliomas,'' and hemangiosarcomas are mostly limited to other organ systems, including the spleen, right atrium, skin, and subcutis; they are less common in other species. 17, 18 Bracken fern carcinogens, often acting synergistically with BPV-2, interfere with multiple pathways encompassing DNA damage/repair mechanisms, 3 activation of specific oncogenes, 39, 41 and growth factor receptors, 5 which eventually perturb control of cell proliferation. Cellular proliferation is, in part, regulated by D-type cyclins, 43 and cyclin D1, one of its members, is specifically involved in the G1/Sphase transition. Two recently published studies report cyclin D1 expression in human breast hemangiomas and hemangiosarcomas 44 and in hemangiosarcomas of the spleen, liver, kidney, and soft tissue of dogs. 53 In the former study, no correlation was seen between cyclin D1 immunoreactivity and malignancy grade. 44 In 2007, Yonemaru et al. found, using immunohistochemistry, that all canine hemangiosarcomas tested displayed cyclin D1 expression, while none of the canine subcutaneous hemangiomas were found to express this protein.
Furthermore, control of cell growth and maintenance of genome stability are controlled by the nuclear phosphoprotein p53. Mutations of p53 occur in 50% of human cancers, 22, 51 including softtissue angiosarcoma, 27, 50 and usually lead to p53 protein accumulation in the nucleus.
The current study of BEH endothelial urinary bladder tumor specimens included the investigation of 1) the expression levels of structural proteins, 2) the possible correlation of structural proteins with pathologic parameters, and 3) the identification of altered expression of the cell-cycle regulatory factors cyclin D1 and p53.
Materials and Methods

Sample collection
From December 2002 to March 2003, a total of 4,026 Friesian cows (after calving and .2 years of age) were slaughtered in the abattoir of Sã o Miguel Island. Rejection due to bladder lesions occurred in 612 animals (15.2%), from which 26 displaying vascular tumors were selected, at random, for the present study. Up to 90% of the animals had hematuria at or before slaughter, and all were known to have grazed on bracken-infested pasture. Their ages ranged from 3 to 12 years (mean, 6). Multiple samples were collected from bladders exhibiting more than 1 tumor (18/26), each sample corresponding to discrete, nonconfluent tumor. Hence, 56 bovine urinary bladder tumors of both endothelial origin were available for immunohistochemical studies. Regional lymph nodes and internal organs were not accessed for metastasis. Tumors were formalin fixed and paraffin embedded, and 3-mm sections were cut for routine histologic diagnosis (hematoxilin and eosin, HE) and immunohistochemical studies. One histologic section was performed in tumors ,3 cm in size, and 2 sections in tumors .3 cm.
Histologic typing and immunohistochemical studies
Histologic typing of vascular tumors was based on World Health Organization established criteria for the diagnosis of urinary bladder tumors in domestic animals, recent publications on BEH-associated bladder lesions, 10, 28, 34 and diagnostic histopathology criteria for human blood vessel tumors. 6 Endothelial tumors were classified as hemangiomas, hemangioendotheliomas, and hemangiosarcomas. Although the designation hemangioendothelioma is infrequently used in veterinary pathology, 10, 16, 26, 32, 33, 52 this category was adopted in the present study to deal with the heterogeneity within this group and assist the correlation between the expression levels of selected proteins and tumor grade. This category includes lesions with microscopic features intermediate between hemangiomas and hemangiosarcomas in terms of cellularity, mitotic activity, presence of well-formed vascular channels, and degree of invasion.
Hemangioendotheliomas show focal invasion of deeper layers of the lamina propria and increased celullarity, opposed to hemangiomas, but have welldifferentiated vessels and lack moderate to high mitotic activity, anastomosing vascular spaces, and increased cellular atypia, characteristics of the hemangiosarcoma. Classification was based on HE staining for all endothelial tumors except 5 solid hemangiosarcomas, in which CD31-positive immunohistochemical staining was contributory to the final diagnosis.
Endothelial tumors were immunohistochemically stained for FVIIIra, PECAM-1, MSA, cyclin D1, p53, and UPIII, as indicated in Table 1 .
Antisera validation
To determine possible cross-reaction of the anti-UPIII antibody with nonurothelial tumors, 8 hemangiomas, 6 hemangioendotheliomas, and 8 hemangiosarcomas were subject to immunohistochemistry with this antibody. Normal blood vessels served as internal positive controls for FVIIIra/CD31, and urothelium served as internal positive controls for UPIII.
All tumors were tested for each antibody within a short period. Hence, variations in antigen retrieval technique overtime were minimal and unimportant to the outcome of the technique.
Human mantle-cell lymphoma was included as a positive control for human cyclin D1 antibody. Heatinduced epitope retrieval was essential for immunodetection of cyclin D1 and was carried out by placing sections in a high pH buffer solution (pH 5 8.0) in a microwave (20 minutes, 750 W). The aggressiveness of the technique occasionally compromised cell/tissue morphology, and for this reason it was not possible to assess cyclin D1 staining in 9 endothelial tumors. Bovine ocular squamous cell carcinoma was used as a positive control for p53 immunodetection. The DO-1 antibody utilized in the study recognizes an epitope present in the N terminus of p53 and cross-reacts with both wild-type and mutant human protein (amino acids [20] [21] [22] [23] [24] [25] . In this study, a 20% cutoff value (.100 labeled tumor cells per 500 tumor cells randomly counted) was accepted as positive staining for p53 and cyclin D1. 25, 49 Negative controls for immunohistochemistry were processed identically to test slides, but the primary antibody was omitted.
Statistical analysis
Association between presence/absence of immunoreactivity for the antibodies tested and pathologic parameters, namely tumor grade/stage, was evaluated using 2-sided Fisher's exact test. Statistical analyses were performed using SPSS Version 14.0 (Chicago, IL, USA). The associations were considered significant when P values were less than 0.05.
Results
Summarized results are shown on Table 2 . Based on evaluation of the HE-stained tissue sections, the 56 endothelial-derived bovine urinary bladder tumors were diagnosed as follows: 21 hemangiomas, 23 hemangiosarcomas, and 12 neoplasms that had microscopic features suggestive of a low-grade tumor that were classified as hemangioendotheliomas ( Fig. 1 ). Growth patterns of vascular tumors ranged from vasoformative to solid, and tumor vessels varied from well formed with a well-defined lumen in hemangiomas to more poorly defined in hemangiosarcomas. The proportion of vasoformative and solid components varied, and only 6 hemangiosarcomas were found to display a full solid growth pattern and epithelioid morphology. In 3 hemangioendotheliomas and 2 other hemangiosarcomas, neoplastic cells were also predominantly epithelioid, with rare spindled areas. Muscle invasion was only seen in 14 hemangiosarcomas. Lymphoplasmacytic and neutrophilic inflammatory infiltrates (often found together, present within the tumor stroma and tumor margins) varied from prominent to slight or absent.
CD31 and FVIIIra
Vascular tumors were further characterized through the use of endothelial markers. CD31 expression was detected in all endothelial tumors examined, including muscle-invasive hemangiosarcomas ( Fig. 2 ). All neoplastic cells within the tumor consistently displayed CD31 immunostaining, which was intense at the cell membrane level. FVIIIra expression was seen in all hemangiomas (20/20) and hemangioendotheliomas (12/12) , and in 15 of 20 hemangiosarcomas (67%). The hemangiosarcomas negative for FVIIIra (6 solid and 1 poorly vasoformative) were all muscle-invasive lesions, and the endothelial origin of these tumors was confirmed by their positive reaction with CD31. Undifferentiated endothelial tumor cells, generally found in areas of solid growth, did not express FVIIIra. The staining was diffusely granular within the cytoplasm of endothelial cells, with occasional staining of plasma within vascular space ( Fig. 3) . It was not possible to assess FVIIIra and CD31 expression in 2 and 6 endothelial tumors, respectively, because of high general background within the vascular space.
Cyclin D1
Normal urothelium surrounding the tumor lesion demonstrated nuclear staining for cyclin D1 in ,5% of basal cells. Moderate to strong nuclear staining was identified in 53% hemangio- { UPIII 5 uroplakin III; FVIIIra 5 factor VIII-related antigen; 2 5 tumor cells showed no immunostaining; + 5 some/all tumor cells showed positive immunostaining; bk 5 excessive background staining within the vascular lumen that impeded proper interpretation; cm 5 compromised tissue morphology due to aggressive high pH antigen retrieval technique; nd 5 not determined.
{ Presence of atypical UPIII pattern in the urothelium covering the endothelial tumor. mas (9/17), 82% hemangioendotheliomas (9/11), and 100% hemangiosarcomas (19/19) . Cyclin D1 expression positively correlates with malignancy grade in vascular tumors. The staining was mainly nuclear, although occasional weak cytoplasmic immunoreactivity was detected ( Fig. 4 ).
p53
Immunoreactive p53 was detected in 30% of the hemangiosarcomas (7/23, 6 solid and 1 poorly vasoformative) and 25% of the hemangioendotheliomas (3/12) ( Table 3 ). Nuclear p53 immunoreactivity was seen in more than 90% of hemangiosarcoma tumor cells ( Fig. 5 ). All p53-positive hemangiosarcomas were muscle-invasive lesions. Staining intensity was moderate to strong, and cytoplasmic p53 staining was never observed. Nuclear p53 positivity graded high in 90% of cells was also seen in 1 hemangioma. In this particular case, not only the tumor but also all capillary Fig. 7 . Hemangioendothelioma in bovine urinary bladder. Urothelium covering endothelial tumor displays atypical uroplakin III reaction, with intense and diffuse staining of cells in the deeper layers (arrow). ImmPRESSperoxidase with Mayer's hematoxylin counterstain. Bar 5 50 mm. Fig. 8 . Hemangiosarcoma in bovine urinary bladder. Heterogenous uroplakin III staining of urothelial cells in von Brü nn Nests within a hemangiosarcoma, with patchy intracytoplasmic positivity (asterisk); superficial cells display normal uroplakin III expression, more intense in the apical border of the cytoplasmic membrane (arrow). ImmPRESS-peroxidase with Mayer's hematoxylin counterstain. Bar 5 30 mm. Inset: Detail of the staining. Bar 5 10 mm. endothelial cells exhibited p53 immunoreactivity. All p53-positive tumors were also positive for cyclin D1, except for 1 hemangioendothelioma.
P53 staining was also found in dysplastic urothelium covering in the vicinity of 2 endothelial malignancies, 1 hemangioendothelioma, and 1 hemangiosarcoma (Fig. 6 ).
UPIII
UPIII expression was not detected in the neoplastic endothelial cells of the 22 vascular tumors evaluated for this marker. A noteworthy finding in this series was that atypical UPIII expression pattern was seen specifically in the urothelium, covering 25% hemangiomas (2/8), 100% hemangioendotheliomas (6/6), and 88% hemangiosarcomas (7/8) . In contrast with the normal UPIII staining pattern, very intense on the apical aspect and cytoplasm of superficial urothelial cells, this atypical staining was characterized by discontinuity of the apical pattern, heterogeneous staining of cells in the deeper layers, and presence of clustered intermediate cells with irregular membranous staining and a diffuse or patchy stain in the cytoplasm (Figs. 7, 8 ). Only 1 of these tumors displayed altered uroplakin distribution within the urothelium distant from the vascular tumor. No overlap in staining pattern was observed between p53-positive urothelial cells and atypical UPIII expression.
Discussion
The current study documents the use of immunohistochemistry as a tool to characterize endothelial-derived urinary bladder tumors developing as a result of bracken fern carcinogens. No loss of CD31 expression was registered in endothelial tumors, and generally all neoplastic cells within these lesions were CD31 positive, as has previously been reported by other authors. 36 CD31 has an extracellular domain that mediates endothelial cellto-cell contact and a cytoplasmic domain with potential sites for phosphorylation after cellular activation, 30 and it has been proposed to be involved in interactive events during angiogenesis. CD31 expression by tumor cells may therefore represent a selective advantage for tumor progression and invasion.
In contrast to CD31, FVIIIra expression was lost in high-grade, muscle-invasive hemangiosarcomas of solid phenotype, negatively correlating with tumor grade and stage.
Through ultrastructural studies in soft-tissue angiosarcomas, Weibel-Palade bodies, which store FVIIIra, were not observed in neoplastic endothe-lium, whereas they were readily identified in the endothelium of capillaries of the surrounding fibrous stroma. 27 This is in agreement with our findings. Previous reports also noted that FVIIIra is seldom expressed in poorly differentiated vascular tumors. 23, 36 Hence, although FVIIIra and CD31 are both specific for the characterization of a vasoformative phenotype, only the latter was found to be consistently expressed by neoplastic endothelial cells, even in poorly differentiated/solid neoplasms. FVIIIra immunoreactivity was occasionally seen in epithelial tumor cells, in a subset of urothelial carcinomas. This was unexpected because this rabbit-anti human FVIIIra antibody is supposed to react exclusively with endothelial cells, megakaryocytes, and platelets in both human and bovine tissue; production of this glycoprotein by cells other than endothelial cells and megakaryocytes has not been described. 48 It is possible that an FVIIIra-like molecule is being coexpressed in bladder carcinoma cells. Alternatively, partial cross-reactivity with another epitope in the urothelium may explain the spurious staining.
Urothelium overlaying endothelial malignancies frequently displayed atypical UPIII expression, quite different from that of normal bladder urothelium and urothelium adjacent to the endothelial tumors. According to other authors, this pattern of expression is diagnostic of severe dysplasia/carcinoma in situ. 1, 37 It is unclear whether urothelial lesions are carcinogen induced and develop together with the endothelial tumor or if a specific microenvironment in the underlying suburothelial space favors the onset of dysplastic changes in the superimposed urothelium.
Evans and Mason demonstrated, for the first time in 1965, undeniable evidence for bracken carcinogenicity. 15 Since then, several studies have shown increased numbers of chromosome aberrations in cattle maintained on natural bracken fern 29 or with overt enzootic hematuria. 24, 29 From the various toxic compounds that have been isolated from bracken fern, unequivocal urinary bladder carcinogenesis has been proved only for ptaquiloside. 19, 20 At sublethal or subtoxic levels, ptaquiloside causes genotoxicity through the formation of a number of different DNA adducts, the main labile adducts occurring at the N-3 of adenine, and to a minor extent with the N-7 of guanine. 21, 31, 42, 47 H-ras activation is also known to be an early event in a rat model of ptaquilosideinduced carcinogenesis. 41 Overexpression of this protein has been documented in cases of bladder neoplasia and cystitis in animals naturally exposed to bracken fern. 39 Cyclin D1 and p53 overexpres-sion was seen in endothelial-derived bovine urinary bladder tumors. Regarding cyclin D1, this overexpression was positively associated with high tumor grade and occurred in 53% of hemangiomas (9/17), 82% of hemangioendotheliomas (9/11), and 95% of hemangiosarcomas (18/19) . Cyclin D1 expression was recently reported in breast vascular tumors in humans, but no correlation with malignancy grade was seen. 44 On the other hand, expression of this protein was seen in 39 of 39 canine hemangiosarcomas of the spleen, liver, kidney, and soft tissue, but none of the subcutaneous hemangiomas tested (n 5 10) displayed cyclin D1 immunoreactivity. 53 In our study, cyclin D1 expression positively correlates with malignancy grade occurring in benign, low-grade, and high-grade vascular tumors. It is possible that this pathway is being differentially regulated in endothelial tumors arising in distinct organ systems.
Abnormal p53 expression was seen in bovine urinary bladder cancer, being present only in muscle-invasive hemangiosarcomas. P53 nuclear accumulation and consequent detection by immunohistochemistry can be due to gene mutation or activation of mechanisms that influence p53 stability. 54 Mutation and deletion of the p53 tumor suppressor gene are the most frequent genetic alterations of epithelial-derived bladder cancer in humans and are associated with advanced disease. 13 Within soft-tissue angiosarcomas, also in humans, 20-50% display p53 overexpression. 27, 54 The results presently obtained are in agreement with previous studies, and a significant correlation occurred between strong positive reactions with p53 and an invasive phenotype in both endothelial and urothelial bladder cancer. BPV-2 status of the tumors was not accessed in this study, and hence no further details can be add to our understanding of its relevance in these cellular specific cellular pathways, in BEH.
In humans, within the spectrum of hemangioendothelioma, several distinct entities are recognized, differing not only histologically but also in terms of epidemiology and biologic behavior. 6, 12 Here, although this term refers exclusively to a histologic pattern, it was seen that tumors within this category are also immunohistochemically distinct from hemangiomas and hemangiosarcomas. FVIIIra expression is maintained, similar to hemangiomas, but the percentage of tumors with cyclin D1 and p53 overexpression resembles that of hemangiosarcomas. It seems that, phenotipically, these lesions are well differentiated, but the cellular pathways involving certain oncogenes and tumor suppressor genes are already impaired.
In BEH no association between histologic grade/stage of bladder lesions and their biologic behavior can be made, because samples are obtained at slaughter and there is, therefore, no treatment or follow up. Nevertheless, there is unquestionable merit in the use of animal models for studying the pathogenesis of endothelial tumors, and, in fact, molecular studies in bovine urinary bladder tumors already provided evidence, for the first time in spontaneous tumors, of the importance of the angiogenesis/chemokine axis in endothelial and urothelial malignancies. 9 Hence, results presented here can be used to the benefit of other species (other domestic animals and man) with the goal of further predicting the outcome of the host.
In conclusion, the data presented in this study show that while CD31 expression was retained by all endothelial tumors examined, FVIIIra was lost in hemangiosarcomas of solid phenotype and was only seldom expressed in poorly differentiated vascular tumors, being therefore less sensitive than CD31 for the characterization of bovine endothelial tumors. The cell cycle regulatory pathways involving cyclin D1 and p53 seem to be altered in urinary bladder tumors in BEH.
As an extention of this work, immunohistochemical studies will further be applied to epithelial-derived bovine urinary bladder tumors, and the distinctive features between the 2 different tumor histotypes will be further addressed.
